Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

rights, build supportive clinical efficacy data and then choose the most expeditious commercialization pathway to make these therapies available to patients in the U.S. and abroad."

Gary Seelhorst, Vice President of Corporate Development, added, "At Imprimis, we have developed a proprietary Asset Review Methodology, or ARM, process, which is designed to produce a complete development and commercialization profile on a product candidate. Using ARM as a guide for decision-making, Imprimis is currently focused on four key therapeutic areas: Ophthalmology, Wound Management, Urology and Pain. We believe these areas maximize the associated commercial opportunity as well as the ability to satisfy unmet medical needs."

In each of these therapeutic areas, Imprimis owns formulations that it believes offer unique competitive advantages in the drug prescribing value chain. Over the past year Imprimis has acquired drug formulations and related intellectual property for formulations it hopes to launch beginning in 2014. Imprimis 2014 Formulation Portfolio Development and Commercialization PlanTherapeutic AreaDisease or Care SettingFormulationProjected Potential Market SizeCommercialization StatusOphthalmologyCataract and Glaucoma Surgery Patients

 

 

Mydriatic Agent and For Intraoperative Floppy-Iris Syndrome (IFIS) in Ocular Surgery Patients

Two or more of Triamcinolone + Moxifloxicin + Vancomycin injectable solutions

 

Lyophilized Epinephrine + Lidocaine/ Phenylephrine + Lidocaine (Shugarcaine) 

>$1B

Pursue out-licensing to pharmacies during 2014

 

 

Pursue a pre-IND Meeting during 2014Wound ManagementRapid Wound Closure for Patients in Kidney Dialysis Centers

Tranexamic Acid + Bacitracin

$100 M - $200 M

Proof of concept (POC) studies in first half 2014; begin out-licensing to pharmacies pend
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th ... a viable method for encouraging people to lose weight. Specifically the study compared control ... weight loss success, adding a financial incentive to the overall incentive of increased health. ...
(Date:8/4/2015)... Santa Barbara, CA (PRWEB) , ... August 04, ... ... if you are suffering from underarm sweat. Evolutions Medical & Day Spa in ... called miraDry, the only non-invasive, FDA cleared treatment that permanently eliminates sweat and ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... of Local Food,” scheduled for Nov. 3 – 4, 2015, at UC San ... sustainably, create new businesses, improve food access, and manage resources efficiently against the ...
(Date:8/4/2015)... ... ... Members receiving care from a doctor who participates in a patient-centered program ... percent lower -- than those members at traditional doctor practices, according to the 2014 ... “The promise of patient-centered, or value-based, care to deliver better quality care at a ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... checking with “Dr. Google” before calling a physician. In an effort to share ... first health care provider in Pennsylvania to publicly share patient satisfaction ratings and ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3
... ... its new relationship with La Maestra Community Health Centers of San Diego, California. ONRAD ... for La Maestra and their patients. , ... Riverside, CA (PRWEB) October 8, 2009 -- ONRAD, Inc. ...
... DALLAS Oct. 8, 2009 The antidote for acute ... liver failure due to most other causes if given before ... colleagues at 21 other institutions have found. Acute liver ... in toxins being released into the bloodstream and brain. Patients ...
... ... cancer therapy affect integration into society,• Marriage is predicted by height, physical functioning, cognitive ... Philadelphia ... long-term effects of cancer treatment on physical health, and results of a new study ...
... Calif., Oct. 7 Dr. Richard Merkin, High Desert Medical ... their 19th annual Senior Expo October 1 at the Antelope ... start, ready for free health screenings including screenings for bone ... of course, seasonal flu shots. The theme for this ...
... Center,s Health Care Report Urge Joint Leadership on Health Reform ... statement released by Bipartisan Policy Center Founders and Advisory Board ... , "After 14 months of work, on June 17, 2009, ... the culmination of months of work as advisors to the ...
... As House and Senate leaders negotiate the final details ... warned today that one provision under consideration, the Community Living ... fiscally irresponsible. Moreover, the long-term cost of this new entitlement, ... it appears to produce a short-term windfall. , "The ...
Cached Medicine News:Health News:ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA 2Health News:Medication effective for acute liver failure in early stages of disease 2Health News:Survivors of Childhood Cancer Less Likely to Marry 2Health News:Survivors of Childhood Cancer Less Likely to Marry 3Health News:Survivors of Childhood Cancer Less Likely to Marry 4Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 2Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 3Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 4Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 2Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 3Health News:Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset 4
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
Medicine Products: